Autopsy report · NCT02648763

Staging Procedures to Diagnose Malignant Pleural Mesothelioma

“due to low/slow accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 7 years 3 months before it stopped.
• 33 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Mesothelioma; Solitary Fibrous Tumor of the Pleura

Participants

33

Sites

1

Countries

United States

Trials that died the same way

• Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
  “Due to slow accrual” (94% match in meaning)
• A Study of Olaparib and Durvalumab in Prostate Cancer
  “Due to low accrual” (88% match in meaning)
• Education for Prevention of Melanoma in Hispanic Populations
  “Low/slow accrual” (86% match in meaning)
• Yoga Therapy in Treating Patients With Malignant Brain Tumors
  “Slow Accruals” (85% match in meaning)
• Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
  “Slow accrual” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.